Transfusion Transmitted Infections in Patients with Haemophilia, a Study from Western Rajasthan, India
Journal: Haematology International Journal (HIJ) (Vol.4, No. 2)Publication Date: 2020-07-03
Authors : Yedale K Kalita JM; Gadepalli R;
Page : 1-3
Keywords : Haemophilia; Transfusion transmitted infection; HBV; HCV; HIV;
- Transfusion Transmitted Infections in Patients with Haemophilia, a Study from Western Rajasthan, India
- The Prevalence of Transfusion Transmitted Infections in Blood Donors and Possible Correlation of Transfusion Transmitted Infections with ABO and Rh Blood Groups Blood Donors in, Tertiary Care Center of SMS Hospital, Jaipur
- Incidence of Transfusion Transmitted Infections at Tezpur Medical College & Hospital, Tezpur, Assam, India. (A Retrospective Study & Personal Experience)
- Seroprevalence of transfusion transmitted infections in voluntary and replacement donors: A five years study
- A Retrospective Study of Screening of Common Transfusion Transmitted Infections in the Blood Bank of a Tertiary Care Centre
Abstract
Introduction: Haemophilia is one of the predominant congenital coagulation disorder and a disease without ethnic or geographic limitations with incidence approximately 20 per 100 000 male births. Haemophilic patients are in regular need of blood and blood products and prone to risk of acquiring infections such as hepatitis B, C (HBV, HCV) and human immunodeficiency virus (HIV). Materials and methods: In this descriptive study, 98 haemophilic patients were selected for screening of HIV I and II, HBV, and HCV through the rapid immunochromatographic test method. Positive cases were confirmed by third generation enzyme linked immunosorbent assay (ELISA). Results: In this study, prevalence of hepatitis B among haemophilia patient was zero and prevalence of hepatitis C and HIV was 1.02% each. Conclusion: Prevalence of transfusion transmitted infections is much lower in this study than previous studies. The use of advanced methods, more sensitive tests, and virally inactivated factor concentrates might contribute to this reduction of viral infections in these patients.
Other Latest Articles
- Who is at Risk? Lessons Learned
- Haemovigilance Fact and Fiction
- Evaluation of Soluble Intercellular Adhesion Molecule-1 and Soluble P Selection in Sickle Cell Disease
- COVID19 War, Triangle with Inflammation and Infection
- Compound Heterozygous Sickle Cell and Beta Thalessemia Trait with High Hb F: A Rare Case from India
Last modified: 2022-09-12 18:13:04